Jain Rita 4
4 · ANAPTYSBIO, INC · Filed Jun 17, 2025
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
Jain Rita
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-06-15−6,030→ 0 total→ Common Stock (6,030 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-06-15−1,300→ 1,300 total→ Common Stock (1,300 underlying) - Exercise/Conversion
Common Stock
2025-06-15+7,330→ 11,864 total
Footnotes (3)
- [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.
- [F3]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.